Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q2 2022 Earnings
REGN
+1.17%
4
May
Confirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
8.93
14.55
20.18
25.8
Details
Expected EPS
9.74
Actual EPS
8.93
Surprise EPS
-0.81
Surprise Percent
+8.32%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 8.93 per share for Q2 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login